Efficacy and safety of rituximab in treating patients with multiple sclerosis (MS): A systematic review and meta-analysis.

Ghajarzadeh, Mahsa; Azimi, Amirreza; Valizadeh, Zahra; Sahraian, Mohammad Ali; Mohammadifar, Mehdi

Ghajarzadeh, Mahsa; Azimi, Amirreza; Valizadeh, Zahra; Sahraian, Mohammad Ali; Mohammadifar, Mehdi.

Afiliación

Ghajarzadeh M; Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran. Electronic address: m-ghajarzadeh@farabi.tums.ac.ir.
Azimi A; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Valizadeh Z; Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran.
Sahraian MA; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadifar M; Department of Radiology, Zanjan university of medical sciences, Iran.

Autoimmun Rev ; 19(8): 102585, 2020 Aug.

Article en En | MEDLINE | ID: mdl-32531469

Asunto(s)

Esclerosis Múltiple/tratamiento farmacológico; Rituximab/efectos adversos; Rituximab/uso terapéutico; Humanos

Palabras clave

Efficacy; Multiple sclerosis; Rituximab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rituximab / Esclerosis Múltiple Tipo de estudio: Systematic_reviews Límite: Humans Idioma: En Revista: Autoimmun Rev Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2020 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google